Skip to Main Content

Paper Details

Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
Haematologica
12
2022
CBF, CBF-AML, FLT3, FLT3-ITD, anthracycline, core binding factor, core binding factor acute myeloid leukemia, core-binding factor, core-binding factor acute myeloid leukemia, inv(16, inv(16), inv(16)(p13q22)/t(16;16)(p13;q22), patients, t(8;21)(q22;q22), trisomy 22
Author NameAffiliation
Marlise R LuskinDana-Farber Cancer Institute
Friedrich St??lzelUniversity Hospital Carl-Gustav-Carus
Richard M StoneDana-Farber Cancer Institute
Christoph R??lligUniversity Hospital Carl-Gustav-Carus
Mark J LevisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Mark J LevisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
  • 1 - 6

Datasets

Release 1.2